drugset / Trial / NCT06518122
A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the drug-drug interaction and safety between HCP1306, RLD2302 and RLD2102 in healthy volunteers.
Timeline
- Start
- 2024-09-01
- Primary completion
- 2025-01-03
- Completion
- 2025-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1306 | Unknown | — | — |
| Subject | RLD2102 | Unknown | — | — |
| Subject | RLD2302 | Unknown | — | — |
Indications
No indication recorded.